Development of an oral DNA anti-cancer vaccine targeting an angiogenic peptide, proadrenomedullin N-terminal 20 peptide (PAMP)

Nucleic acid-based anticancer vaccines are becoming a very active field in the fight against cancer. The goal of this thesis was to generate an oral DNA vaccine targeting the angiogenic peptide, proadrenomedullin N-terminal 20 peptide (PAMP). Methods: An expression plasmid (PcPAMP) was generated by fusing the tetanus toxin epitopes P2 and P30 to the mouse PAMP sequence to counteract self-tolerance, and the empty plasmid was used as a negative control (PcNeg). The plasmids were introduced into Salmonella typhimurium bacteria that were then converted into bacterial ghosts. C57BL/6J mice were orally immunized with the ghosts five times at 2-week intervals. Then, B16-F10 melanoma cells were injected either into the tail vein to generate lung metastases or subcutaneously to generate cutaneous melanoma. Furthermore, naive CD4+ T cells were exposed to PAMP, and their secretome was analyzed by proximity extension assays. Results: In the lung metastasis model, a humoral and cellular immune response was evidenced by the presence of significantly higher amounts of anti-PAMP IgGs and spleen CD8+ T cells in the PcPAMP-vaccinated mice. Although the number and size of lung metastases were similar between both experimental groups, there was a notable reduction in intratumoral angiogenesis and cancer cell proliferation in the PcPAMP group. Furthermore, the treatment led to intense infiltration of lymphocytes, including regulatory T cells, and M2-like macrophages into the metastases. In the cutaneous melanoma model, similar results were obtained. Despite of a high level of anti-PAMP IgGs and a marked reduction of intratumoral angiogenesis in the PcPAMP-vaccinated mice, the treatment did not reduce tumor volume or improve survival rates. A remarkable infiltration of lymphocytes and macrophages was also observed in the tumors of vaccinated animals. Additionally, the incubation of naive CD4+ T cells with PAMP induced the up-regulation of IL-1β, IL-6, IL-7, IL-12, IL-27, TNFα, and FGF21, and the down-regulation of IL-16. Conclusions: Although the vaccine was not effective in reducing tumor growth, new proliferative and immune functions have been described for PAMP. These new functions include induction of melanoma proliferation and modulation of lymphocyte and macrophage tumor infiltration dynamics.

Grantor dc:publisher

Universidad de La Rioja (España)

Year dc:date

2025

Author dc:creator

• Kalathil Raju, Tom

Contributors dc:contributor

• Martínez Ramírez, Alfredo (Universidad de La Rioja)

Statement dc:rights

• LICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI

Language dc:language

eng

Repository record dc:identifier

https://dialnet.unirioja.es/servlet/oaites?codigo=396430

OAI identifier oai:identifier

oai:dialnet.unirioja.es:TES0000023209